Arrowhead Pharmaceuticals, Inc. (ARWR)

NASDAQ: ARWR · Real-Time Price · USD

74.52

+0.11 (0.15%)

At close: Jun 12, 2026, 4:00 PM EDT

74.51

-0.01 (-0.01%)

After-hours: Jun 12, 2026, 6:35 PM EDT

Arrowhead Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 12, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Cap	10,497	4,680	2,409	2,883	3,502	6,513
Market Cap Growth	351.90%	94.27%	-16.45%	-17.66%	-46.23%	47.75%
Enterprise Value	10,098	4,653	2,615	2,879	3,227	6,171
Last Close Price	74.52	34.49	19.37	26.87	33.05	62.43
PS Ratio	16.88	5.64	678.45	11.98	14.40	47.10
PB Ratio	17.06	10.10	13.19	10.63	8.79	15.93
P/TBV Ratio	16.91	9.95	12.70	10.57	8.74	15.84
P/FCF Ratio	-	29.83	-	-	-	44.08
P/OCF Ratio	-	26.07	-	-	-	38.02
EV/Sales Ratio	16.23	5.61	736.40	11.96	13.27	44.62
EV/EBITDA Ratio	-	38.06	-	-	-	-
EV/EBIT Ratio	-	47.32	-	-	-	-
EV/FCF Ratio	-	29.66	-	-	-	41.77
Debt / Equity Ratio	2.28	1.44	4.43	1.30	0.19	0.06
Debt / EBITDA Ratio	-	6.00	-	-	-	-
Debt / FCF Ratio	-	4.68	-	-	-	0.17
Net Debt / Equity Ratio	2.00	-0.10	1.08	-0.07	-0.74	-0.84
Net Debt / EBITDA Ratio	-6.24	-0.39	-0.34	0.11	1.75	2.43
Net Debt / FCF Ratio	-24.09	-0.30	-0.33	0.06	1.56	-2.32
Asset Turnover	0.32	0.66	0.00	0.33	0.35	0.22
Quick Ratio	0.55	4.02	6.34	3.83	2.72	2.58
Current Ratio	6.23	4.86	6.74	3.95	2.92	2.62
Return on Equity (ROE)	-46.81%	8.67%	-254.98%	-59.33%	-42.67%	-32.36%
Return on Assets (ROA)	-12.35%	4.55%	-62.81%	-28.51%	-26.02%	-24.18%
Return on Invested Capital (ROIC)	-14.28%	12.15%	-147.37%	-57.36%	-45.47%	-45.20%
Return on Capital Employed (ROCE)	-13.74%	8.83%	-70.85%	-33.80%	-31.97%	-28.51%
FCF Yield	-	3.35%	-	-	-	2.27%
Buyback Yield / Dilution	-9.83%	-11.67%	-12.21%	-1.26%	-1.62%	-3.00%
Total Shareholder Return	-9.83%	-11.67%	-12.21%	-1.26%	-1.62%	-3.00%

SEC Filings: 10-K · 10-Q